Search Results
Jan 29, 2026, 11:08 ET Innovative Labs Scales Health and Wellness Manufacturing with New High-Capacity Utah Facility
Innovative Labs, a leading contract development and manufacturing organization (CDMO), announced today the opening of a new facility in Springville, Utah. This expansion significantly increases production capacity and introduces advanced
More news about: Innovative Labs
Jan 29, 2026, 00:46 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
(4) % CDMO1,166
More news about: Piramal Pharma Limited
Jan 29, 2026, 00:35 ET Piramal Pharma Limited Announces Results for Q3 and 9M FY26
(4) % CDMO1,166
More news about: Piramal Pharma Limited
Jan 28, 2026, 11:11 ET Alcami Promotes Guy Kubi to Chief Operating Officer
Jan. 28, 2026 /PRNewswire/ -- Alcami Corporation ("Alcami"), a leading U.S.-based contract development and manufacturing organization (CDMO), today announced the promotion of Guy Kubi to Chief Operating Officer (COO), effective immediately.
More news about: Alcami
Jan 28, 2026, 07:00 ET Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
Jan. 28, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that it has received the EcoVadis' Platinum Sustainability Rating, the highest level of recognition for corporate sustainability performance.
More news about: Samsung Biologics
Jan 27, 2026, 08:51 ET Cohere Beauty Introduces the Fragrance Collective at Cosmoprof Miami 2026
technical and regulatory demands of fragrance manufacturing, The Fragrance Collective is anchored by Cohere Beauty's Cedar Grove facility, one of the few CDMO operations in North America purpose-built for fragrance blending under the industry's most stringent quality standards."As trends move quickly
More news about: Cohere Beauty
Jan 27, 2026, 08:00 ET Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
Jan. 27, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced an upgrade to its Viral Clearance laboratory capabilities at its Philadelphia campus.
More news about: Minaris Advanced Therapies
Jan 23, 2026, 09:00 ET Coating Place Announces Leadership Appointments to Support Next Phase of Growth
reporting to Chief Executive Officer Tim Breunig, and will also join the company's Board of Directors. Mr. Damani brings extensive experience in the CDMO sector, with leadership roles spanning the pharmaceutical, nutraceutical, and animal health industries. He is widely recognized for building strong
More news about: Coating Place
Jan 21, 2026, 02:20 ET Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Jan. 21, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), reported financial results for the fourth quarter and fiscal year 2025.
More news about: Samsung Biologics
Jan 20, 2026, 08:00 ET Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership
Jan. 20, 2026 /PRNewswire/ -- Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics ("Atsena"), a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or
More news about: Genezen
Jan 19, 2026, 11:44 ET Alcami Acquires RTP Facility to Further Expand Biologic Capabilities
Jan. 19, 2026 /PRNewswire/ -- Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence
More news about: Alcami
Jan 16, 2026, 06:50 ET Avid Bioservices nomme Rich McAvoy au poste de Directeur commercial
TUSTIN, Calif., 16 janvier 2026 /PRNewswire/ -- Avid Bioservices, entreprise de sous-traitance pharmaceutique (CDMO) de premier plan proposant des services de développement de processus et de bonnes pratiques de fabrication actuelles pour les produits biopharmaceutiques,
More news about: Avid Bioservices
Jan 16, 2026, 06:47 ET Avid Bioservices nombra a Rich McAvoy como director comercial
16 de enero de 2026 /PRNewswire/ -- Avid Bioservices, una organización líder de desarrollo y fabricación por contrato (CDMO) que brinda servicios de desarrollo de procesos y fabricación CGMP para productos biofarmacéuticos, anunció hoy el nombramiento de Rich McAvoy como
More news about: Avid Bioservices
Jan 15, 2026, 21:49 ET Avid Bioservices ernennt Rich McAvoy zum Chief Business Officer
16. Januar 2026 /PRNewswire/ -- Avid Bioservices, ein führendes Auftragsentwicklungs- und Herstellungsunternehmen (CDMO), das Dienstleistungen im Bereich Prozessentwicklung und CGMP-Herstellung für biopharmazeutische Produkte anbietet, gab heute die Ernennung von Rich
More news about: Avid Bioservices
Jan 15, 2026, 13:53 ET Avid Bioservices Appoints Rich McAvoy as Chief Business Officer
Jan. 15, 2026 /PRNewswire/ -- Avid Bioservices, a leading contract development and manufacturing organization (CDMO) providing process development and CGMP manufacturing services for biopharmaceutical products, today announced the appointment of Rich McAvoy as Chief
More news about: Avid Bioservices
Jan 15, 2026, 13:36 ET Avid Bioservices Appoints Rich McAvoy as Chief Business Officer
Jan. 15, 2026 /PRNewswire/ -- Avid Bioservices, a leading contract development and manufacturing organization (CDMO) providing process development and CGMP manufacturing services for biopharmaceutical products, today announced the appointment of Rich McAvoy as Chief
More news about: Avid Bioservices
Jan 15, 2026, 11:11 ET Kindeva Announces Leadership Transition to Drive Strategic Growth
Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in
More news about: Kindeva
Jan 15, 2026, 08:30 ET Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
The transaction establishes Zydus' advanced manufacturing facilities in the global biologics contract development and manufacturing organization ("CDMO") business. All acquired manufacturing assets and operations will be housed under a newly formed, dedicated U.S. based subsidiary named Zylidac Bio
More news about: Zydus Lifesciences Limited
Jan 15, 2026, 08:30 ET Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks
life-saving medicines is key to a flexible supply chain that can respond to unforeseen demand changes. This webinar examines how a globally harmonized CDMO operating model can support rapid technology transfer and production across a standardized network. However, the constantly evolving landscape driven
More news about: Xtalks
Jan 15, 2026, 08:00 ET Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production
Jan. 15, 2026 /PRNewswire/ -- Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new facility opened in May 2025 had completed GMP facility validation in October 2025, and has been fully operational with on-going
More news about: Frontage Laboratories, Inc.
Jan 14, 2026, 09:00 ET Coating Place Secures Growth Capital Investment by 1315 Capital
Coating Place, a leading U.S.-based contract development and manufacturing organization (CDMO), has secured a strategic, growth investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm. Coating Place delivers
More news about: 1315 Capital
Jan 13, 2026, 18:46 ET Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
Medical's bioconjugates.LOTTE Biologics has been expanding its capabilities as a global contract development and manufacturing organization (CDMO), particularly in the field of monoclonal and multispecific antibodies, antibody-drug conjugates (ADCs), and advanced bioconjugation services. LOTTE
More news about: LOTTE BIOLOGICS
Jan 13, 2026, 18:00 ET Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
Medical's bioconjugates.LOTTE Biologics has been expanding its capabilities as a global contract development and manufacturing organization (CDMO), particularly in the field of monoclonal and multispecific antibodies, antibody-drug conjugates (ADCs), and advanced bioconjugation services. LOTTE
More news about: Rakuten Medical, Inc.
Jan 13, 2026, 04:18 ET ESTEVE acquisirà la business unit Infusion Specialty Therapies di TerSera Therapeutics, espandendo la presenza negli Stati Uniti
in diverse aree terapeutiche. Oltre alla nostra innovativa attività farmaceutica, offriamo servizi completi di produzione e sviluppo su contratto (CDMO), specializzati nella produzione di principi attivi farmaceutici (API) attraverso strutture di livello mondiale in Spagna, Messico, Cina e Stati Uniti.Il
More news about: ESTEVE
Jan 13, 2026, 04:17 ET ESTEVE adquire a Unidade de Negócios de Terapias Especiais de Infusão da TerSera Therapeutics, expandindo a presença nos EUA
várias áreas terapêuticas. Além de nosso negócio farmacêutico inovador, oferecemos serviços abrangentes de Fabricação e Desenvolvimento por Contrato (CDMO), especializados na produção de Ingredientes Farmacêuticos Ativos (APIs) por meio de instalações de classe mundial na Espanha, México, China e EUA.O
More news about: ESTEVE